Invasive Cardiology
New Product Introduction: Invasive Cardiology (MM31 Process)
- Vendors wanting to introduce a new product needs to complete an MM31 form
- Completed forms need to be returned to Supply Coordinators located in the CCL inventory room
- Communication regarding MM31 including negotiations will be performed by Materials Management
- MM31s are reviewed by Invasive Cardiology Administration
- Supply Chain Management will inform vendor of the status of the MM31’s decision
Items taken into consideration for MM31 approval:
- Evaluation products comply with the Network’s No-charge Policy
- Pricing
- Free shipping
- Consignment ability
- Swapping expiring product and/or old product for new product
- Terms & Conditions
Primary Types of MM31s
- MM31 New Product (Emergent Use)
- MM31 New Product needs Evaluation
- MM31 New Product replacing current product, (no financial impact & same vendor)
- MM31 New Product competes with & potentially replaces current products, (new or prior vendor)